Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Digital Holographic Microscopy Reveals How Cancer Cells Gain Extra Chromosomes

By LabMedica International staff writers
Posted on 22 Nov 2010
Cell biologists have used digital holographic microscopy to show how abnormal distribution of chromosomes takes place in some types of cancer cells.

Investigators at Lund University (Sweden) used Wilms' tumor as a model for cancers with trisomies. More...
They made movies of the tumor cells growing in culture. To prevent damage to the cells during photography, they employed digital holographic microscopy, a novel technique by which the cells were exposed only to weak laser light for very limited time periods.

Results published in the November 8, 2010, online edition of the journal Proceedings of the [U.S.] National Academy of Sciences (PNAS) contrasted with the popular theory that dysfunction of the spindle assembly checkpoint (SAC) leads to an accumulation of trisomies through failure to correctly segregate sister chromatids in successive cell divisions. Instead, results of the current study showed that trisomic cells could form even in the presence of a functional SAC through tripolar cell divisions in which sister chromatid separation proceeded in a regular fashion, but cytokinesis failure nevertheless led to an asymmetrical segregation of chromosomes into two daughter cells.

"We were even more surprised to see that two of the three poles often fused together to form one daughter cell. This daughter cell thus got extra copies of one or more chromosomes. When we continued to film the cells it emerged that they could continue to divide, and they thus gave rise to new cancer cells with a chromosome set that was different from the original cell,” said first author Dr. David Gisselsson Nord, associate professor of pathology at the Lund University.

"We have long known that changes in the genetic make-up of body cells play a part in the development of tumors. However, we do not know a lot about how the genetic changes in the tumor cells actually come about. Above all, it has been difficult to understand why many tumor cells contain extra copies of one or more chromosomes, despite the fact that this is the most common type of chromosome abnormality in cancer cells,” said Dr. Nord.

Related Links:
Lund University



Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.